AP Biosciences, Inc.(TW:6945)
NT$117.50+2.50 (+2.17%)
TW:6945
AP Biosciences, Inc. financials statements
NT$117.50
At close:+2.50 (+2.17%)
AP Biosciences, Inc. (6945) Income Statement
AP Biosciences, Inc. Income Statement
Last quarter (Q2 2026), AP Biosciences, Inc.'s total revenue was NT$0.00. In Q2, AP Biosciences, Inc.'s net income was NT$-217.29M. See AP Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 0.00 | NT$ 0.00 | NT$ 32.25M | NT$ 0.00 | NT$ 6.99M | |
| NT$ -25.52M | NT$ -17.48M | NT$ 32.25M | NT$ -8.68M | NT$ 6.99M | |
| NT$ 430.86M | NT$ 421.57M | NT$ 379.73M | NT$ 297.50M | NT$ 193.71M | |
| Depreciation and Amortization | NT$ 25.52M | NT$ 17.48M | NT$ 12.58M | NT$ 8.68M | NT$ 8.86M |
| NT$ -430.86M | NT$ -403.61M | NT$ -325.51M | NT$ -290.07M | NT$ -177.86M | |
| NT$ -456.38M | NT$ -439.06M | NT$ -347.48M | NT$ -288.54M | NT$ -186.72M | |
| NT$ 11.61M | NT$ 16.31M | NT$ 8.18M | NT$ 8.96M | NT$ -889.00K | |
| NT$ -444.77M | NT$ -422.75M | NT$ -339.30M | NT$ -288.54M | NT$ -187.61M | |
| NT$ -444.77M | NT$ -422.75M | NT$ -339.30M | NT$ -288.54M | NT$ -187.61M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -5.23 | NT$ -5.61 | NT$ -5.24 | NT$ -5.48 | NT$ -3.89 |
| Diluted EPS | NT$ -5.23 | NT$ -5.61 | NT$ -5.24 | NT$ -5.48 | NT$ -3.89 |
| Weighted Average Shares Outstanding | 85.04M | 75.29M | 64.75M | 52.65M | 48.23M |
| Weighted Average Shares Outstanding (Diluted) | 85.04M | 75.29M | 64.75M | 52.65M | 48.23M |
Currency in TWD

